1. Home
  2. ICCC vs CUBA Comparison

ICCC vs CUBA Comparison

Compare ICCC & CUBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • CUBA
  • Stock Information
  • Founded
  • ICCC 1982
  • CUBA 1992
  • Country
  • ICCC United States
  • CUBA United States
  • Employees
  • ICCC N/A
  • CUBA N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • CUBA Investment Managers
  • Sector
  • ICCC Health Care
  • CUBA Finance
  • Exchange
  • ICCC Nasdaq
  • CUBA Nasdaq
  • Market Cap
  • ICCC 48.3M
  • CUBA 39.0M
  • IPO Year
  • ICCC 1987
  • CUBA N/A
  • Fundamental
  • Price
  • ICCC $5.07
  • CUBA $2.53
  • Analyst Decision
  • ICCC
  • CUBA
  • Analyst Count
  • ICCC 0
  • CUBA 0
  • Target Price
  • ICCC N/A
  • CUBA N/A
  • AVG Volume (30 Days)
  • ICCC 27.6K
  • CUBA 93.9K
  • Earning Date
  • ICCC 05-14-2025
  • CUBA 01-01-0001
  • Dividend Yield
  • ICCC N/A
  • CUBA 20.83%
  • EPS Growth
  • ICCC N/A
  • CUBA N/A
  • EPS
  • ICCC N/A
  • CUBA N/A
  • Revenue
  • ICCC $26,493,169.00
  • CUBA N/A
  • Revenue This Year
  • ICCC N/A
  • CUBA N/A
  • Revenue Next Year
  • ICCC N/A
  • CUBA N/A
  • P/E Ratio
  • ICCC N/A
  • CUBA N/A
  • Revenue Growth
  • ICCC 51.63
  • CUBA N/A
  • 52 Week Low
  • ICCC $3.34
  • CUBA $2.25
  • 52 Week High
  • ICCC $5.82
  • CUBA $4.14
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 42.10
  • CUBA 52.69
  • Support Level
  • ICCC $5.01
  • CUBA $2.45
  • Resistance Level
  • ICCC $5.72
  • CUBA $2.59
  • Average True Range (ATR)
  • ICCC 0.18
  • CUBA 0.08
  • MACD
  • ICCC -0.05
  • CUBA 0.01
  • Stochastic Oscillator
  • ICCC 14.96
  • CUBA 56.14

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About CUBA Herzfeld Caribbean Basin Fund Inc. (The)

Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.

Share on Social Networks: